98%
921
2 minutes
20
Objective: To identify the patterns of nonprescription psychoactive substance (PAS) use among persons with spinal cord injury (SCI) and the relationships with demographic and injury characteristics.
Design: Cross-sectional, self-report assessment (SRA).
Setting: A medical university in the southeastern United States.
Participants: The participants (N=4670) were identified through a specialty hospital and 2 state-based surveillance registries.
Interventions: Not applicable.
Main Outcome Measures: Participants completed SRAs and reported the past 3 months' use of the following substances for which they did not have a prescription: cannabis, cocaine, amphetamine-type stimulants, inhalants, sedatives/hypnotics and sleeping pills, hallucinogens, and opioids. PAS use was grouped into 4 categories: none, cannabis use only, use of cannabis and other PAS, and use of other PAS only.
Results: Of the 4577 participants who responded to the PAS use questions, 24.1% reported using at least 1 PAS without a prescription. Cannabis was the most frequently reported substance (16.4%), followed by sedatives or sleeping pills (8.0%). By PAS use group, 12.1% reported use of cannabis use only, followed by use of other PAS only (7.7%) and use of cannabis and other PAS (4.3%). There were significant differences among the groups of use by nearly all personal characteristics.
Conclusions: The use of nonprescription PASs is prevalent among adults with chronic SCI, and there are clear differences in patterns and characteristics of use.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202538 | PMC |
http://dx.doi.org/10.1016/j.apmr.2021.08.005 | DOI Listing |
Mali Med
November 2024
Centre hospitalier universitaire Yalgado OUEDRAOGO, Service de Psychiatrie.
Spectrochim Acta A Mol Biomol Spectrosc
February 2025
Department of Physiology, Faculty of Medicine, Gaziantep Islam, Science and Technology University, Gaziantep, Türkiye. Electronic address:
Substance use disorders pose significant health risks and treatment challenges due to the diverse interactions between substances and their impact on physical and mental health. The chemical effects of multiple substance use on bodily fluids are not yet fully understood. Therefore, this study aimed to investigate the chemical changes induced by a combination of substances compared to a control group.
View Article and Find Full Text PDFHealth Promot Chronic Dis Prev Can
April 2024
School of Public Health Sciences, University of Waterloo, Waterloo, Ontario, Canada.
Introduction: Research characterizing substance use disparities between gender minority youth (GMY) and non-GMY (i.e. girls and boys) is limited.
View Article and Find Full Text PDFJ Phys Chem B
October 2023
Faculty of Technology, Department of Mathematics, Physics and Computation, University of the State of Rio de Janeiro, Resende, Rio de Janeiro 27537-000, Brazil.
Cannabis has shown promise in treating various neurological disorders, including Alzheimer's disease (AD). AD is a devastating neurodegenerative disorder that affects millions of people worldwide. Current treatments for AD are limited and are not very effective.
View Article and Find Full Text PDFTunis Med
January 2023
Clinique Universitaire de Psychiatrie et de Psychologie Médicale, CHU Sylvanus Olympio-Lomé, Hôpital Psychiatrique de ZébéAného, Togo / Université de Lomé, Faculté des Sciences de la Santé.